BlackRock Institutional Trust’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $563K | Hold |
108,366
| – | – | ﹤0.01% | 3424 |
|
|
2016
Q3 | $2.73M | Buy |
108,366
+631
| +0.6% | +$15.9K | ﹤0.01% | 2930 |
|
|
2016
Q2 | $2.66M | Sell |
107,735
-282
| -0.3% | -$6.97K | ﹤0.01% | 2926 |
|
|
2016
Q1 | $3.13M | Sell |
108,017
-1,095
| -1% | -$31.7K | ﹤0.01% | 2858 |
|
|
2015
Q4 | $4.05M | Buy |
109,112
+1,145
| +1% | +$42.5K | ﹤0.01% | 2823 |
|
|
2015
Q3 | $5.26M | Sell |
107,967
-13,861
| -11% | -$675K | ﹤0.01% | 2686 |
|
|
2015
Q2 | $8.4M | Buy |
121,828
+39,383
| +48% | +$2.72M | ﹤0.01% | 2511 |
|
|
2015
Q1 | $2.95M | Buy |
82,445
+15,600
| +23% | +$558K | ﹤0.01% | 2942 |
|
|
2014
Q4 | $845K | Buy |
66,845
+515
| +0.8% | +$6.51K | ﹤0.01% | 3379 |
|
|
2014
Q3 | $1.02M | Buy |
66,330
+15,418
| +30% | +$237K | ﹤0.01% | 3312 |
|
|
2014
Q2 | $1.38M | Buy |
50,912
+7,202
| +16% | +$195K | ﹤0.01% | 3323 |
|
|
2014
Q1 | $1.17M | Buy |
43,710
+15,261
| +54% | +$409K | ﹤0.01% | 3355 |
|
|
2013
Q4 | $699K | Buy |
28,449
+14,474
| +104% | +$356K | ﹤0.01% | 3491 |
|
|
2013
Q3 | $449K | Buy |
13,975
+6,479
| +86% | +$208K | ﹤0.01% | 3541 |
|
|
2013
Q2 | $222K | Buy |
+7,496
| New | +$222K | ﹤0.01% | 3624 |
|